Benzinga · Aug 14, 2026
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5
Maxim Group analyst Anthony Vendetti maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and lowers the price target from $13 to $5.
NM
NASDAQ · NMTC
NeuroOne Medical Technologies Corporation
Healthcare · Medical - Devices
$2.03
Down-$0.12 (-5.58%)
Updated Aug 24, 2026, 8:58 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 29.33M
- P/E ratio
- -5.35
- Dividend yield
- 0.00%
- 52-week range
- $0.70 – $5.40
- Volume
- 35.34K
- Avg. volume
- 334.87K
Price performance
NMTC price history
1M range · 0 trading sessions · Daily adjusted prices
NMTC does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest NMTC news
The latest Smart Investors Daily articles mentioning NMTC.
Stock researchCompany · Overview
NMTC research
Overview
Company profile and research snapshot.
Company profile
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $3.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 14, 2026 | Maxim Group | Buy | — |
| May 13, 2026 | Ladenburg Thalmann | Buy | — |
| Mar 2, 2026 | Jones Trading | Buy | — |
| Sep 9, 2025 | Maxim Group | Buy | — |
| May 5, 2025 | Ladenburg Thalmann | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 13, 2026
NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript
Benzinga · Mar 3, 2026
NEUROONE MEDICAL shares are trading higher after a Form 4 filing showed its Chief Business Officer purchased 1.50 million shares at an average price of $0.45.
Benzinga · Mar 2, 2026
Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5
Jones Trading analyst Justin Walsh initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $1.5.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
